ctrl K

Price Alert

GT Biopharma Inc. (GTBP)

NASDAQ: GTBP · Real-Time Price · USD

1.36

-0.09 (-6.21%)

At close: Aug 15, 2025, 3:59 PM

1.36

-0.37%

After-hours: Aug 15, 2025, 06:10 PM EDT

GT Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.95M	1.08M	5.67M	8.97M
Short-Term Investments	n/a	12.89M	10.84M	23.01M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	9K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	281K	n/a	n/a	n/a
Total Current Assets	4.23M	14.06M	16.56M	32.17M
Property-Plant & Equipment	n/a	53K	165K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	53K	174K	n/a
Total Assets	4.23M	14.11M	16.74M	32.17M
Account Payables	3.85M	4.33M	3.14M	8.19M
Deferred Revenue	n/a	n/a	n/a	1.9M
Short-Term Debt	n/a	n/a	n/a	31K
Other Current Liabilities	252K	1.05M	19K	-1.76M
Total Current Liabilities	5.9M	6.63M	4.94M	10.26M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	64K	n/a
Total Liabilities	5.9M	6.63M	5M	10.26M
Total Debt	n/a	58K	174K	31K
Common Stock	2K	1K	33K	1.15M
Retained Earnings	-695.23M	-682.07M	-674.47M	-653.58M
Comprehensive Income	n/a	n/a	n/a	1.11M
Shareholders Equity	-1.67M	7.48M	11.73M	21.91M
Total Investments	n/a	12.89M	10.84M	23.01M